Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study

BACKGROUND: Patients with coronary chronic total occlusion (CTO) require effective antiplatelet therapy after percutaneous coronary intervention (PCI). Ticagrelor has more pronounced platelet inhibition than clopidogrel. However, the most appropriate dose of ticagrelor in East Asian populations rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong, Zhao, Hong-wei, Wang, Cheng-fu, Zhang, Xiao-jiao, Tao, Jie, Cui, Chun-sheng, Meng, Qing-kun, Zhu, Yu, Luo, De-feng, Hou, Ai-jie, Luan, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057632/
https://www.ncbi.nlm.nih.gov/pubmed/32138662
http://dx.doi.org/10.1186/s12872-019-01307-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057632/
https://www.ncbi.nlm.nih.gov/pubmed/32138662
http://dx.doi.org/10.1186/s12872-019-01307-0

Ejemplares similares